Tobacco use disorder occurs when the use of tobacco harms a personâs health or social functioning, or when a person becomes dependent on tobacco. Tobacco may be consumed in the form of cigarettes, smokeless tobacco products (eg, snuff, chewing tobacco), cigars, or pipes.
This condition can be treated. Talk to your doctor if you think you have tobacco use disorder.
Tobacco products contain nicotine, which is transported to the brain and causes pleasurable sensations. The effects of nicotine dissipate within a few minutes, however. This cause tobacco users to continue using tobacco to maintain the pleasurable effects and prevent withdrawal. Other chemicals in tobacco products may also contribute to tobacco use disorder.
The following factors increase your chance of developing tobacco use disorder. If you have any of these risk factors, tell your doctor:
If you experience any of these symptoms, do not assume it is due to tobacco use disorder. These symptoms may be caused by other health conditions. If you experience any one of them, see your physician.
Consequences of tobacco use disorder include:
Your doctor will ask about your symptoms and medical history, and perform a physical exam. He or she will ask you specific questions about your tobacco use, such as how long you have been using tobacco and how often you use it.
Your doctor can test your lung function and compare the results to those of a non-smoking person. The results can be given to you as your âlung age.â Knowing your âlung ageâ right after having the test done may help you to stop smoking.
Talk with your doctor about the best treatment plan for you. Treatment options include the following:
Nicotine replacement therapy (NRT) are used to relieve nicotine withdrawal symptoms. Examples of NRT products include: nicotine gum, lozenges, nasal sprays, patches, and inhalers. Sometimes, these products are used in combination, which may help some people stay smoke-free. Since NRT does not produce the pleasurable effects of tobacco, there is little chance that these products will be abused.
According to studies, NRT may help you to:
Talk to you doctor about how to best use this therapy. Combining behavioral therapy with NRT may be even more helpful.
Behavioral therapies to help people quit using tobacco include:
Research has shown that certain medications, including the antidepressants bupropion (Zyban) and varenicline tartrate (Chantix) may help people quit smoking. Varenicline tartrate helps ease symptoms of nicotine withdrawal and may block the effects of nicotine if people resume smoking. One potential side effect with these medicines is that they may increase the risk of serious mood and behavior changes in some people.
Even if you are not a smoker, exposure to smoke from tobacco products on a regular basis is dangerous, sometimes even life-threatening.
Here are the US Surgeon Generalâs conclusions about effects from inhaling secondhand smoke:
The best way to prevent tobacco use disorder is to never use tobacco products. Tobacco products are highly addictive. Also, avoid regular exposure to secondhand smoke.
American Cancer Society
Canadian Cancer Society
The Lung Association
Diagnostic codes (ICD9-CM). Surgeon General website. Available at: http://www.surgeongeneral.gov/tobacco/codes.htm. Accessed September 25, 2006.
Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA. 2008;299:2037-2047. In: Tobacco use disorder. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Accessed May 22, 2008.
Questions about smoking, tobacco, and health. American Cancer Society website. Available at: http://www.cancer.org/. Accessed September 25, 2006.
Research report series: tobacco addiction. National Institute on Drug Abuse website. Available at: http://www.nida.nih.gov/ResearchReports/Nic...ne/Nicotine.html. Accessed September 25, 2006.
2/27/2007 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Etter JF, Stapleton JA. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control. 2006;280-285.
9/24/2007 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: LF Stead, T Lancaster. Interventions to reduce harm from continued tobacco use [review]. Cochrane Database of Systematic Reviews. 2007;3.
3/25/2008 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336:598-600.
10/14/2008 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Shiffman S, Ferguson SG. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction. 2008;103:557-563.
12/16/2008 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ. 2008;179:135-144.
2/5/2009 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Cochran CJ, Gallicchio L, Miller SR, Zacur H, Flaws JA. Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol. 2008;112:1037-1044.
2/17/2009 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2009;(1):CD001007.
7/6/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: Myung SK, McDonnell DD, Kazinets G, Seo HG, Moskowitz JM. Effects of Web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:929-937.
7/21/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: Lancaster T, Stead L. Self-help interventions for smoking cessation. C ochrane Database Syst Rev. 2009;(2):CD001118.
11/13/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php: Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009;66(11):1253-1262.
12/21/2009 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Whittaker R, Borland R, Bullen C, et al. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2009;(4):CD006611.
Last reviewed February 2010 by Theodor B. Rais, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.